Grupo Reig Jofre to combine organic growth with acquisitions
Grupo Reig Jofre combinará crecimiento orgánico y adquisiciones
Intel ID : 230478
| Synopsis |
|
Spain-based Grupo Reig Jofre (BME: RJF) designed a 5-year business plans that includes a combination between organic growth with acquisitions, as reported by the company through a relevant fact published by Securities Commission CNMV on 15 October 2015. In addition, the company will begin a roadshow with analysts and domestic and international investors to present the company after its merger with Natraceutical, to review its business performance in the first semester of 2015 and comment on its future plans.
(content in spanish)
La empresa española Grupo Reig Jofre (BME: RJF) ha diseñado un plan de negocio a cinco años que contempla la combinación entre crecimiento orgánico y adquisiciones, según ha comunicado la propia compañía a través de un hecho relevante remitido a la Comisión Nacional del Mercado de Valores (CNMV) el 15 de octubre de 2015. Además, la compañía va a iniciar un roadshow con analistas e inversores nacionales e internacionales para presentar la compañía tras la fusión con Natraceutical, repasar la evolución del negocio en la primera mitad del ejercicio y comentar sobre sus planes de futuro. |
Relevant Documents
| Notice / Relevant Fact | 15 Oct 2015 | Grupo_Reig_Jofre_Hecho_Relevante_2015.pdf | ES |
|
| Intel ID | 230478 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Grupo Reig Jofre
(31 Dec 2022) |
Revenue: EUR 275,87m EBITDA: EUR 30,57m Net Debt: EUR 647,38m People: 1221 |
|
| Date |
 |
|
| Country |  |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.